Alexandre Schaan de Quadros, MD, PhD

Publicações mais relevantes e recentes abaixo. Para a lista completa de publicações, por favor acesse http://lattes.cnpq.br/

 

1. Sebben J, Pinto Ribeiro DR, Lopes RD, et al. The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart Journal 2015, published online. doi: 10.1016/j.ahj.2015.10.003

2. Abelin AP, David RB, Gottschall CA, Quadros AS. Accuracy of dedicated risk scores in patients undergoing primary percutaneous coronary intervention in daily clinical practice. Can J Cardiol. 2014 Jan;30(1):125-31.

3. Ribeiro DR, Ramos AM, Vieira PL, et al. High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction. Arq Bras Cardiol. 2014; 103: 69-75.

4. David RB, Almeida ED, Cruz LV, Sebben JC, Feijó IP, Schmidt KE, Avena LM, Gottschall CA, Quadros AS. Diabetes mellitus and glucose as predictors of mortality in primary coronary percutaneous intervention. Arq Bras Cardiol. 2014 Oct;103(4):323-30

5. Sociedade Brasileira de Cardiologia, Lorga Filho AM, Azmus AD, Soeiro AM, Quadros AS, Avezum A Jr, et al. Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology. Arq Bras Cardiol. 2013 Sep;101(3 Suppl 3):1-95.

6. Schmidt MM, Lopes RD, Newby LK, Moura MR, Stochero L, Gottschall CM, Quadros AS. Anger control and cardiovascular outcomes. Int J Cardiol. 2013 Oct 9;168(4):4338-9.

7. Quadros AS, Cambruzzi E, Sebben J, David RB, Abelin A, Welter D, Sarmento-Leite R, Mehta RH, Gottschall CA, Lopes RD. Red versus white thrombi in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: clinical and angiographic outcomes. Am Heart J. 2012 Oct;164(4):553-60.

8. Signori LU, Quadros AS, Sbruzzi G, Dipp T, Lopes RD, Schaan BD. Endothelial function in patients with slow coronary flow and normal coronary angiography.Clinics. 2012;67(6):677-80.

9. Sbruzzi G, Quadros AS, Ribeiro RA, Abelin AP, Berwanger O, Plentz RD, Schann  BD. Intracoronary ultrasound-guided stenting improves outcomes: a meta-analysis of randomized trials. Arq Bras Cardiol. 2012 Jan;98(1):35-44.

10. Schmidt MM, Quadros AS, Abelin AP, Minozzo EL, Wottrich SH, Kunert HZ, Vigueras ES, Ruschel PP, Sarmento-Leite R, Gottschall CA. Psychological characteristics of patients undergoing percutaneous coronary interventions. Arq Bras Cardiol. 2011 Oct;97(4):331-7

11. Quadros AS, Lima TC, Rodrigues AP, Modkovski TB, Welter DI, Sarmento-Leite R, Gottschall CA. Quality of life and health status after percutaneous coronary intervention in stable angina patients: results from the real-world practice. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):954-60.

12. Quadros AS, Welter DI, Camozzatto FO, Chaves A, Mehta RH, Gottschall CA, Lopes RD. Identifying patients at risk for premature discontinuation of thienopyridine after coronary stent implantation. Am J Cardiol. 2011 Mar 1;107(5):685-9.

13. Abreu-Silva EO, Quadros AS, Zanettini MT, Gottschall CA. Angiographic evaluation of plaque volume and cardiovascular events after coronary stent implantation. Arq Bras Cardiol. 2010 Dec;95(6):679-84.

14. Ghem C, Sarmento-Leite RE, de Quadros AS, Rossetto S, Gottschall CA. Serum bilirubin concentration in patients with an established coronary artery disease. Int Heart J. 2010 Mar;51(2):86-91.

15. Bertoluci MC, Quadros AS, Sarmento-Leite R, Schaan BD. Insulin resistance and triglyceride/HDLc index are associated with coronary artery disease. Diabetol Metab Syndr. 2010 Feb 3; 2:11.

16. Augustin AC, de Quadros AS, Sarmento-Leite RE. Early sheath removal and ambulation in patients submitted to percutaneous coronary intervention: a randomised clinical trial. Int J Nurs Stud. 2010 Aug;47(8):939-45.

17. Quadros AS, Diemer F, Welter D, Modkovski T, Sarmento-Leite R, Gottschall CA. Validation of a risk score for target vessel revascularization after coronary stent implantation. J Invasive Cardiol. 2009 Dec;21(12):618-22.

18. Souza EN, Quadros AS, Maestri R, Albarrán C, Sarmento-Leite R. Predictors of quality of life change after an acute coronary event. Arq Bras Cardiol. 2008 Oct;91(4):229-35, 252-9.

19. Knebel AV, Cardoso CO, Correa Rodrigues LH, Sarmento-Leite RE, de Quadros AS, Mascia Gottschall CA. Safety and feasibility of transulnar cardiac catheterization. Tex Heart Inst J. 2008;35(3):268-72.

20. Cardoso CO, de Quadros AS, Mattos LA, Gottschall CA, Sarmento-Leite RE, Marin-Neto JA. Use of drug-eluting stents in Brazil: the CENIC (National Registry of Cardiovascular Interventions) registry. Arq Bras Cardiol. 2007 Dec;89(6):356-61.

21. Schaan BD, Quadros AS, Sarmento-Leite R, De Lucca G Jr, Bender A, Bertoluci M. 'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease. Cardiovasc Diabetol. 2007 Jul 25;6:19.